Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Uterine Cervical Neoplasms 12 Papillomavirus Infections 11 Neoplasms 10 Breast Neoplasms 9 Uterine Cervical Dysplasia 7 Persistent Infection 5 Condylomata Acuminata 5 Prostatic Neoplasms 4 Melanoma 4 Anus Neoplasms 4 Vulvar Neoplasms 3 Lung Neoplasms 3 Herpes Zoster 3 Glioblastoma 3 Carcinoma, Non-Small-Cell Lung 3 Vaginal Neoplasms 2 Sarcoma 2 Neuroblastoma 2 Neoplasm Metastasis 2 Influenza, Human 2 HIV Infections 2 Glioma 2 Colonic Neoplasms 2 Breast Neoplasms, Male 2 Wilms Tumor 1 Whooping Cough 1 Waldenstrom Macroglobulinemia 1 Triple Negative Breast Neoplasms 1 Tetanus 1 Squamous Cell Carcinoma of Head and Neck 1

Interventions

Cisplatin 55 Carboplatin 50 pembrolizumab 42 Paclitaxel 42 Gemcitabine 28 Pemetrexed 23 Radiotherapy 21 Magnetic Resonance Spectroscopy 20 Radiotherapy, Intensity-Modulated 18 Cetuximab 18 Docetaxel 17 Specimen Handling 16 Nivolumab 16 Fluorouracil 16 Cyclophosphamide 14 durvalumab 13 Bevacizumab 13 Sorafenib 12 Radiation 11 130-nm albumin-bound paclitaxel 11 Sunitinib 10 Platinum 10 1,2-diaminocyclohexaneplatinum II citrate 10 osimertinib 9 Oxaliplatin 8 Irinotecan 8 Ipilimumab 8 Everolimus 8 Drug Therapy 8 Capecitabine 8

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Carcinoma × Vaccines × Clear all

NCT00684294 2020-03-02

Auto TAG

Mary Crowley Medical Research Center

Phase 1 Terminated

Carcinoma, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡